Cancer Grand Challenges: taming T-cell receptors and targeting the undruggable with new technologies


Gemma Balmer-Kemp (left) is the Head of Research for Cancer Grand Challenges, an initiative co-founded by Cancer Research UK (London, UK) and the National Cancer Institute (MD, USA) with the mission to fund global teams to tackle the biggest problems in cancer research. Here, she discusses some of the latest teams to receive funding from Cancer Grand Challenges, the challenges they are addressing in T-cell receptor binding prediction and the drivers of pediatric solid tumors, and exciting techniques to have emerged from previous Cancer Grand Challenges teams. What is Cancer Grand Challenges presenting at AACR 2024? We have just launched...

To view this content, please register now for access

Join our member community for FREE to access a collection of journal and online-only features, including:

  • Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
  • The latest news and journal updates delivered straight to your inbox when you want it
  • Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
  • Priority registration to webinars, panel discussions and events
  • Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!